Effects of itopride hydrochloride on plasma gut-regulatory peptide and stress-related hormone levels in healthy human subjects

Pharmacology

Volumn 77, Issue 3, 2006, Pages 115-121

  Katagiri, Fumihiko ^a   Shiga, Toru ^a   Inoue, Shin ^a   Sato, Yuhki ^a   Itoh, Hiroki ^a   Takeyama, Masaharu ^a  

^a OITA UNIVERSITY HOSPITAL   (Japan)

Author keywords

ACTH; CCK; Cortisol; HPA axis; Itopride; Motilin; Somatostatin; Stress

Indexed keywords

CHOLECYSTOKININ; GASTRIN; HORMONE; HYDROCORTISONE; ITOPRIDE; MOTILIN; PEPTIDE; SOMATOSTATIN;

ADULT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; CORTICOTROPIN BLOOD LEVEL; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG EFFECT; DRUG HALF LIFE; DRUG MECHANISM; HUMAN; HYDROCORTISONE BLOOD LEVEL; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; STOMACH EMPTYING; STRESS;

ADRENOCORTICOTROPIC HORMONE; ADULT; BENZAMIDES; BENZYL COMPOUNDS; CHOLECYSTOKININ; GASTRINS; GASTROINTESTINAL AGENTS; HUMANS; HYDROCORTISONE; MALE; MOTILIN; SOMATOSTATIN;

EID: 33746366470     PISSN: 00317012     EISSN: None     Source Type: Journal    
DOI: 10.1159/000093485     Document Type: Article

References (37)

1. Talley NJ, Stanghellini V, Heading RC, Koch KL, Malagelada JR, Tytgat GNJ: Functional gastroduodenal disorders. Gut 1999;45(suppl II):II37-II42.
2. 2 antagonist with anticholinesterase activity in gastrointestinal motor activity: comparison with domperidone and neostigmine. Gastroenterology 1991;99:401-408.
3. Kok LP, Yap ILE, Guan RYC: Psychosocial aspects of non-ulcer dyspepsia. Singapore Med J 1989;30:346-349.
4. Miyabo S, Hisada T, Asato T, Mizushima N, Ueno K: Growth hormone and cortisol responses to psychological stress: comparison of normal and neurotic subjects. J Clin Endocrinol Metab 1976;42:1158-1162.
5. Ferriani RA, Silva de Sa MF: Effect of venipuncture stress on plasma prolactin levels. Int J Gynaecol Obstet 1985;23:459-462.
6. Vachon P, Moreau JP: Serum corticosterone and blood glucose in rats after two jugular vein blood sampling methods: comparison of the stress response. Contemp Top Lab Anim Sci 2001;40:22-24.
7. Itoh H, Nagano T, Takeyama M: Effect of cisapride on plasma levels of motilin, gastrin, somatostatin and secretin in man. Pharm Pharmacol Commun 2000;6:533-538.
8. Itoh H, Nagano T, Takeyama M: Effects of mosapride citrate on human plasma levels of motilin, gastrin, somatostatin, and secretin. Biol Pharm Bull 2001;24:1072-1075.
9. Takeyama M, Matsuo H, Mori K: Enzyme immunoassay of gastrin in human plasma. Chem Pharm Bull 1993;41:2197-2199.
10. Katagiri F, Inoue S, Sato Y, Itoh H, Takeyama M: Ecabet sodium raises plasma calcitonin gene-related peptide and substance P in healthy human subjects. J Pharm Pharmacol 2005;57:799-805.
11. Katagiri F, Inoue S, Itoh H, Takeyama M: Clinical application of an enzyme immunoassay for cholecystokinin-like immunoreactive substance for determination of the human plasma levels: the effect of metoclopramide on gastrointestinal peptides and stress-related hormones. J Peptide Sci 2006;12:311-320.
12. Naito T, Itoh H, Yasunaga F, Takeyama M: Hange-shashin-to raises levels of somatostatin, motilin, and gastrin in the plasma of healthy subjects. Biol Pharm Bull 2002;25:327-331.
13. Nagano T, Itoh H, Soeda F, Takeyama M: Enzyme immunoassay of adrenocorticotropic hormone-like immunoreactive substance in human plasma. Jpn J Hosp Pharm 1999;25:257-263.
14. Kitagawa T, Shimozono T, Aikawa T, Yoshida T, Nishimura H: Preparation and characterization of hetero-bifunctional cross-linking reagents for protein modifications. Chem Pharm Bull 1981;29:1130-1135.
15. Singh SS, Jain M, Sharma K, Shah B, Vyas M, Thakkar P, Shah R, Singh S, Lohray B: Quantitation of itopride in human serum by high-performance liquid chromatography with fluorescence detection and its application to a bioequivalence study. J Chromatgr B Analyt Technol Biomed Life Sci 2005;818:213-220.
16. Ling N, Burgus R, Rivier J, Vale W, Brazeau P: The use of mass spectrometry in deducing the sequence of somatostatin - a hypothalamic polypeptide that inhibits the secretion of growth hormone. Biochem Biophys Res Commun 1973;50:127-133.
17. Schrumpf E: The inhibitory action of somatostatin on the stomach. Adv Exp Med Biol 1978;106:235-240.
18. Hostein J, Janssens J, Vantrappen G, Peeters TL, Vandeweerd M, Leman G: Somatostatin induces ectopic activity fronts of the migrating motor complex via a local intestinal mechanism. Gastroenterology 1984;87:1004-1008.
19. Seal A, Yamada T, Debas H, Hollinshead J, Osadchey B, Aponte G, Walsh J: Somatostatin-14 and -28: clearance and potency on gastric function in dogs. Am J Physiol 1982;243:G97-G102.
20. Grider JR: Neurotransmitters mediating the intestinal peristaltic reflex in the mouse. J Pharmacol Exp Ther 2003;307:460-467.
21. Itoh Z, Honda R, Hiwatashi K, Takeuchi S, Aizawa I, Takayanagi R, Couch EF: Motilin-induced mechanical activity in the canine alimentary tract. Scand J Gastroenterol Suppl 1976;39:93-110.
22. Szelenyi I: Cholinergic components in the gastrin pathway of gastric acid stimulation. Experientia 1980;36:973-974.
23. Kawashima K, Ishihara S, Mohammad AKR, Moriyama N, Kazumori H, Suetsugu H, Sato H, Fukuda R, Adachi K, Shibata M, Onodera S, Chiba T, Kinoshita Y: Localization of calcitonin gene-related peptide receptor in rat gastric mucosa. Peptide 2002;23:955-966.
24. Poitras P, Dumont A, Cuber JC, Trudel L: Cholinergic regulation of motilin release from isolated canine intestinal cells. Peptides 1993;14:207-213.
25. Herranz R: Cholecystokinin antagonists: pharmacological and therapeutic potential. Med Res Rev 2003;23:559-605.
26. 2-receptor agonists on the release of cholecystokinin-like immunoreactivity from rat neostriatum. Eur J Pharmacol 1984;101:119-125.
27. Tsubouchi T, Saito T, Mizutani F, Yamauchi T, Iwanaga Y: Stimulatory action of itopride hydrochloricle on colonic motor activity in vitro and in vivo. J Pharmacol Exp Ther 2003;306:787-793.
28. Tornello S, Orti E, Alejandro F, De Nicola A, Rainbow TC, McEwen BS: Regulation of glucocorticoid receptors in brain by corticosterone treatment of adrenalectomized rats. Neuroendocrinology 1982;35:411-417.
29. Harbuz MS, Lightman SL: Stress and the hypothalamo-pituitary-adrenal axis: acute, chronic and immunological activation. J Endocrinol 1992;134:327-339.
30. Hiroshige T, Sakakura M: Stress-induced activation of phosphorylase in the rat adenohypophysis. Endcrinol Jpn 1969;16: 469-471.
31. Hagan DM, Brooks AN: Dopaminergic regulation of adrenocorticotrophic hormone, alpha-melanocyte-stimulating hormone and cortisol secretion in the ovine fetus. J Endocrinol 1996;151:439-447.
32. Katagiri F, Shiga T, Sato Y, Inoue S, Itoh H, Takeyama M: Comparison of the effects of cytoprotective drugs on human adrenocorticotropic hormone and cortisol levels with continual stress exposure. Biol Pharm Bull 2005;28:2146-2148.
33. Fukudo S, Nomura T, Hongo M: Impact of corticotropin-releasing hormone on gastrointestinal motility and adrenocorticotropic hormone in normal controls and patients with irritable bowel syndrome. Gut 1998;42:845-849.
34. Cremonini F, Delgado-Aros S, Talley NJ: Functional dyspepsia: drugs for new (and old) therapeutic targets. Best Pract Res Clin Gastroenterol 2004;18:717-733.
35. Otsubo T, Mizokami Y, Shiraishi T, Narasaka T, Nakamura H, Takeyama H, Noritake M, Matsuoka K: Effect of itopride hydrochloride on non-ulcer dyspepsia. Rinsho Iyaku 1998;14:2585-2588.
36. Otaka M, Jin M, Odashima M, Matsuhashi T, Wada I, Horikawa Y, Komatsu K, Ohba R, Oyake J, Hatakeyama N, Watanabe S: New strategy of therapy for functional dyspepsia using famotidine, mosapride and amitriptyline. Aliment Pharmacol Ther 2005;21(suppl 2):42-46.
37. Talley NJ: Evaluation of drug treatment in irritable bowel syndrome. Br J Clin Pharmacol 2003;56:362-369.